Showing results (1281-1290 of 2,085) with videos related to
Sort By:
Pageof 209
American Journal of Veterinary Research|November 1, 1980
Evaluation of an enzyme-labeled antiglobulin test for anti-Brucella immunoglobulin G among 3 cattle populationsB W Stemshorn, K H Nielsen, B S Samagh, et al.Cancer|July 1, 1993
Familial clusters of nasopharyngeal carcinoma and salivary gland carcinomas in Greenland nativesH Albeck, J Bentzen, H H Ockelmann, et al.The Annals of Thoracic Surgery|April 27, 2010
Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trialSune Damgaard, Claus H Nielsen, Lars W Andersen, et al.The Journal of Orthopaedic and Sports Physical Therapy|January 1, 1992
Body composition of collegiate football players: bioelectrical impedance and skinfolds compared to hydrostatic weighingR A Oppliger, D H Nielsen, A C Shetler, et al.Clinical Immunology (Orlando, Fla.)|July 26, 2008
The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosisChris J Hedegaard, Martin Krakauer, Klaus Bendtzen, et al.Physical Review Letters|March 5, 2009
Laser-induced alignment and orientation of quantum-state-selected large moleculesLotte Holmegaard, Jens H Nielsen, Iftach Nevo, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 1, 1991
Immune dysfunction in multiple myeloma. Reduced natural killer cell activity and increased levels of soluble interleukin-2 receptorsH Nielsen, H J Nielsen, N Tvede, et al.Science (New York, N.Y.)|July 7, 2007
Identification of active edge sites for electrochemical H2 evolution from MoS2 nanocatalystsThomas F Jaramillo, Kristina P Jørgensen, Jacob Bonde, et al.The British Journal of Dermatology|September 5, 2002
Incidence of allergic contact sensitization in Danish adults between 1990 and 1998; the Copenhagen Allergy Study, DenmarkN H Nielsen, A Linneberg, T Menné, et al.British Journal of Anaesthesia|February 1, 1990
Spinal analgesia with plain 0.5% bupivacaine administered at spinal interspace L2-3 or L4-5K H Olsen, T H Nielsen, E Kristoffersen, et al.Pageof 209